Related Experiment Videos
Postantibiotic effect of a combination of antimicrobial agents on pseudomonas aeruginosa
Abstract:
Treatment of severe Pseudomonas infections often calls for multidrug therapy. Combinations of aminoglycosides, beta-lactams and/or quinolones are generally administered, the effect of which may be additive, synergistic or indifferent. The present in vitro study was designed to find out the exact outcome of the postantibiotic effect (PAE). The minimal inhibitory concentrations and the PAE of three antibiotics (amikacin, ceftazidime and ciprofloxacin) were determined both singly and in combination. Ceftazidime alone exhibited a negative PAE but a synergistic effect was observed for the combination of ceftazidime with amikacin. The combination of ceftazidime with ciprofloxacin and ciprofloxacin with amikacin however gave an indifferent PAE. This synergistic PAE of amikacin with ceftazidime has a significant effect on designing optimal dosage regimens.
Insights
This study found that combining ceftazidime with amikacin creates a synergistic postantibiotic effect (PAE) against Pseudomonas infections. This combination is crucial for optimizing antibiotic treatment regimens.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Severe Pseudomonas infections often require multidrug therapy.
- Antibiotic combinations can yield additive, synergistic, or indifferent effects.
- Understanding the postantibiotic effect (PAE) is vital for treatment optimization.
Purpose of the Study:
- To determine the in vitro postantibiotic effect (PAE) of amikacin, ceftazidime, and ciprofloxacin, both individually and in combination.
- To identify synergistic or antagonistic interactions between these antibiotics against Pseudomonas.
- To inform the design of effective multidrug regimens for severe Pseudomonas infections.
Main Methods:
- Determination of minimal inhibitory concentrations (MICs) for amikacin, ceftazidime, and ciprofloxacin.
- In vitro assessment of the postantibiotic effect (PAE) for each antibiotic alone and in various combinations.
- Analysis of antibiotic interactions to classify effects as additive, synergistic, or indifferent.
Main Results:
- Ceftazidime alone demonstrated a negative PAE.
- A synergistic PAE was observed for the combination of ceftazidime and amikacin.
- Combinations of ceftazidime with ciprofloxacin and ciprofloxacin with amikacin exhibited indifferent PAE.
Conclusions:
- The synergistic PAE of amikacin and ceftazidime is a significant finding for clinical application.
- This synergistic interaction suggests potential for improved therapeutic outcomes in treating Pseudomonas infections.
- Optimized dosage regimens incorporating this synergistic combination may enhance treatment efficacy.